Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 68

Similar articles for PubMed (Select 22580763)

1.

Serine protease inhibitor A3 in atherosclerosis and aneurysm disease.

Wågsäter D, Johansson D, Fontaine V, Vorkapic E, Bäcklund A, Razuvaev A, Mäyränpää MI, Hjerpe C, Caidahl K, Hamsten A, Franco-Cereceda A, Wilbertz J, Swedenborg J, Zhou X, Eriksson P.

Int J Mol Med. 2012 Aug;30(2):288-94. doi: 10.3892/ijmm.2012.994. Epub 2012 May 9.

PMID:
22580763
2.

Activation of transglutaminase type 2 for aortic wall protection in a rat abdominal aortic aneurysm formation.

Munezane T, Hasegawa T, Suritala, Tanaka A, Okada K, Okita Y.

J Vasc Surg. 2010 Oct;52(4):967-74. doi: 10.1016/j.jvs.2010.04.049. Epub 2010 Jul 7.

3.

Mast cells modulate the pathogenesis of elastase-induced abdominal aortic aneurysms in mice.

Sun J, Sukhova GK, Yang M, Wolters PJ, MacFarlane LA, Libby P, Sun C, Zhang Y, Liu J, Ennis TL, Knispel R, Xiong W, Thompson RW, Baxter BT, Shi GP.

J Clin Invest. 2007 Nov;117(11):3359-68.

4.

Critical role of mast cell chymase in mouse abdominal aortic aneurysm formation.

Sun J, Zhang J, Lindholt JS, Sukhova GK, Liu J, He A, Abrink M, Pejler G, Stevens RL, Thompson RW, Ennis TL, Gurish MF, Libby P, Shi GP.

Circulation. 2009 Sep 15;120(11):973-82. doi: 10.1161/CIRCULATIONAHA.109.849679. Epub 2009 Aug 31.

5.

Role of vascular endothelial growth factor-A in development of abdominal aortic aneurysm.

Kaneko H, Anzai T, Takahashi T, Kohno T, Shimoda M, Sasaki A, Shimizu H, Nagai T, Maekawa Y, Yoshimura K, Aoki H, Yoshikawa T, Okada Y, Yozu R, Ogawa S, Fukuda K.

Cardiovasc Res. 2011 Jul 15;91(2):358-67. doi: 10.1093/cvr/cvr080. Epub 2011 Mar 24.

6.

Identification, origins and the diurnal role of the principal serine protease inhibitors in human tear fluid.

Sathe S, Sakata M, Beaton AR, Sack RA.

Curr Eye Res. 1998 Apr;17(4):348-62.

PMID:
9561826
7.

Cathepsin L expression and regulation in human abdominal aortic aneurysm, atherosclerosis, and vascular cells.

Liu J, Sukhova GK, Yang JT, Sun J, Ma L, Ren A, Xu WH, Fu H, Dolganov GM, Hu C, Libby P, Shi GP.

Atherosclerosis. 2006 Feb;184(2):302-11. Epub 2005 Jun 27.

PMID:
15982660
8.

The pathophysiology of abdominal aortic aneurysm growth: corresponding and discordant inflammatory and proteolytic processes in abdominal aortic and popliteal artery aneurysms.

Abdul-Hussien H, Hanemaaijer R, Kleemann R, Verhaaren BF, van Bockel JH, Lindeman JH.

J Vasc Surg. 2010 Jun;51(6):1479-87. doi: 10.1016/j.jvs.2010.01.057.

9.

Transient exposure to elastase induces mouse aortic wall smooth muscle cell production of MCP-1 and RANTES during development of experimental aortic aneurysm.

Colonnello JS, Hance KA, Shames ML, Wyble CW, Ziporin SJ, Leidenfrost JE, Ennis TL, Upchurch GR Jr, Thompson RW.

J Vasc Surg. 2003 Jul;38(1):138-46.

PMID:
12844103
10.

L-selectin-mediated neutrophil recruitment in experimental rodent aneurysm formation.

Hannawa KK, Eliason JL, Woodrum DT, Pearce CG, Roelofs KJ, Grigoryants V, Eagleton MJ, Henke PK, Wakefield TW, Myers DD, Stanley JC, Upchurch GR Jr.

Circulation. 2005 Jul 12;112(2):241-7. Epub 2005 Jul 5.

11.

Ccr5 but not Ccr1 deficiency reduces development of diet-induced atherosclerosis in mice.

Braunersreuther V, Zernecke A, Arnaud C, Liehn EA, Steffens S, Shagdarsuren E, Bidzhekov K, Burger F, Pelli G, Luckow B, Mach F, Weber C.

Arterioscler Thromb Vasc Biol. 2007 Feb;27(2):373-9. Epub 2006 Nov 30.

12.

Cathepsin K deficiency reduces elastase perfusion-induced abdominal aortic aneurysms in mice.

Sun J, Sukhova GK, Zhang J, Chen H, Sjöberg S, Libby P, Xia M, Xiong N, Gelb BD, Shi GP.

Arterioscler Thromb Vasc Biol. 2012 Jan;32(1):15-23. doi: 10.1161/ATVBAHA.111.235002. Epub 2011 Aug 4.

13.

Mast cell chymase and tryptase in abdominal aortic aneurysm formation.

Wang Y, Shi GP.

Trends Cardiovasc Med. 2012 Aug;22(6):150-5. doi: 10.1016/j.tcm.2012.07.012. Epub 2012 Aug 14. Review.

14.

Free-radical scavenger edaravone inhibits both formation and development of abdominal aortic aneurysm in rats.

Morimoto K, Hasegawa T, Tanaka A, Wulan B, Yu J, Morimoto N, Okita Y, Okada K.

J Vasc Surg. 2012 Jun;55(6):1749-58. doi: 10.1016/j.jvs.2011.11.059. Epub 2012 Feb 15.

15.

Mutants of plasminogen activator inhibitor-1 designed to inhibit neutrophil elastase and cathepsin G are more effective in vivo than their endogenous inhibitors.

Stefansson S, Yepes M, Gorlatova N, Day DE, Moore EG, Zabaleta A, McMahon GA, Lawrence DA.

J Biol Chem. 2004 Jul 16;279(29):29981-7. Epub 2004 May 6.

17.

Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient mice.

Lewis P, Stefanovic N, Pete J, Calkin AC, Giunti S, Thallas-Bonke V, Jandeleit-Dahm KA, Allen TJ, Kola I, Cooper ME, de Haan JB.

Circulation. 2007 Apr 24;115(16):2178-87. Epub 2007 Apr 9.

18.

Do cathepsins play a role in abdominal aortic aneurysm pathogenesis?

Sukhova GK, Shi GP.

Ann N Y Acad Sci. 2006 Nov;1085:161-9.

PMID:
17182932
19.

Group X secretory PLA2 in neutrophils plays a pathogenic role in abdominal aortic aneurysms in mice.

Watanabe K, Fujioka D, Saito Y, Nakamura T, Obata JE, Kawabata K, Watanabe Y, Mishina H, Tamaru S, Hanasaki K, Kugiyama K.

Am J Physiol Heart Circ Physiol. 2012 Jan 1;302(1):H95-104. doi: 10.1152/ajpheart.00695.2011. Epub 2011 Oct 7.

20.

Egr-1 deficiency in bone marrow-derived cells reduces atherosclerotic lesion formation in a hyperlipidaemic mouse model.

Albrecht C, Preusch MR, Hofmann G, Morris-Rosenfeld S, Blessing E, Rosenfeld ME, Katus HA, Bea F.

Cardiovasc Res. 2010 May 1;86(2):321-9. doi: 10.1093/cvr/cvq032. Epub 2010 Jan 28.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk